STDs, Cytokines, and Hormonal Contraception
STD、细胞因子和激素避孕
基本信息
- 批准号:6925116
- 负责人:
- 金额:$ 13.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:Neisseria gonorrhoeaeT lymphocytebacterial proteinsbiomarkercell population studycellular immunitycervical /vaginal smearclinical researchcontraceptivescytokinedisease /disorder proneness /riskfemalegenital secretiongonorrheahuman subjecthumoral immunityinflammationmembrane proteinsmucosal immunitypatient oriented researchprogesteronereproductive system pharmacologysample collectiontissue /cell culturetransdermal drug deliveryvagina
项目摘要
DESCRIPTION (provided by applicant): Candidate: Dr. Ghanem, M.D., is an Assistant Professor of Infectious Diseases and a Ph.D. candidate in the Graduate Training Program in Clinical Investigation at Johns Hopkins University School of Medicine. The goal of this K23 resubmission is to enhance his practical research skills and laboratory-based skills through focused didactics and the combined expertise of mentors and collaborators. These skills will complement the theoretical skills he has acquired thus far in his training, allowing him to become an independent and productive translational researcher.
Background: Over 100 million women worldwide use hormonal contraceptives (HC). Their effects on mucosal and systemic immune responses are poorly understood. Observational studies have linked HC use to increased risk of sexually transmitted infection (STI) acquisition, including HIV. Preliminary Data: We have shown that cytokine production in a human-derived cervical and vaginal epithelial cell culture model was influenced by sex hormones in a compartment-specific manner. This finding was extended to a longitudinal study of 967 women where progesterone based HC were found to be independent predictors of lower genital tract inflammation.
Specific Aims: 1) To compare cervicovaginal lavage fluid to endocervical, ectocervical, and vaginal wicks in evaluating lower genital tract mucosal immune responses; 2) To determine whether the use of HC affects cervicovaginal levels of soluble and cellular markers of inflammation in women infected with Neisseria gonorrhoeae, before and after therapy; and 3) To determine whether the use of HC affects systemic humoral and T-cell responses directed against N. gonorrhoeae outer membrane proteins.
Significance: The findings from this proposal will help define optimal methods to measure genital immune responses; they will provide data that may guide the introduction of STI screening strategies specifically targeting HC users, and they will help define the potential role of sex hormones as adjuvants for mucosal vaccines in women.
描述(由申请人提供):候选人:Dr. Ghanem,M.D.,是传染病的助理教授,约翰霍普金斯大学医学院临床研究研究生培训项目的候选人。这个K23重新提交的目标是通过重点教学和导师和合作者的综合专业知识来提高他的实践研究技能和实验室技能。这些技能将补充他迄今为止在培训中获得的理论技能,使他成为一名独立和富有成效的翻译研究人员。
背景:全世界有超过1亿妇女使用激素避孕药(HC)。它们对粘膜和全身免疫反应的影响知之甚少。观察性研究已将HC使用与包括HIV在内的性传播感染(STI)风险增加联系起来。初步数据:我们已经表明,在人源性宫颈和阴道上皮细胞培养模型中细胞因子的产生受到性激素的影响。这一发现扩展到967名妇女的纵向研究,其中孕激素为基础的HC被发现是下生殖道炎症的独立预测因子。
具体目标:1)比较宫颈阴道灌洗液与宫颈内、宫颈外和阴道吸液芯在评估下生殖道粘膜免疫应答方面的作用; 2)确定HC的使用是否影响淋病奈瑟菌感染妇女治疗前后宫颈阴道可溶性和细胞炎症标志物的水平;和3)确定HC的使用是否影响针对N.淋病外膜蛋白。
重要性:该提案的发现将有助于确定测量生殖器免疫反应的最佳方法;它们将提供可能指导专门针对HC使用者的STI筛查策略的引入的数据,并且它们将有助于确定性激素作为女性粘膜疫苗佐剂的潜在作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KHALIL G GHANEM其他文献
KHALIL G GHANEM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KHALIL G GHANEM', 18)}}的其他基金
STD/HIV PREVENTION TRAINING CENTER AT JOHNS HOPKINS
约翰霍普金斯大学性病/艾滋病预防培训中心
- 批准号:
8846764 - 财政年份:2014
- 资助金额:
$ 13.39万 - 项目类别:
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
激素避孕药的使用持续时间:免疫反应
- 批准号:
8442373 - 财政年份:2011
- 资助金额:
$ 13.39万 - 项目类别:
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
激素避孕药的使用持续时间:免疫反应
- 批准号:
8607111 - 财政年份:2011
- 资助金额:
$ 13.39万 - 项目类别:
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
激素避孕药的使用持续时间:免疫反应
- 批准号:
8225194 - 财政年份:2011
- 资助金额:
$ 13.39万 - 项目类别:
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
激素避孕药的使用持续时间:免疫反应
- 批准号:
8108059 - 财政年份:2011
- 资助金额:
$ 13.39万 - 项目类别:
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
激素避孕药的使用持续时间:免疫反应
- 批准号:
8145148 - 财政年份:2010
- 资助金额:
$ 13.39万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 13.39万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 13.39万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 13.39万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 13.39万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




